Cervical cancer in patients infected with the human immunodeficiency virus

Cancer

Volumn 112, Issue 12, 2008, Pages 2683-2689

  Leitao Jr , Mario M ^a,b   White, Paul ^a   Cracchiolo, Bernadette ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cervical cancer; Human immunodeficiency virus; Immune suppression

Indexed keywords

ADULT; ARTICLE; CANCER PREVENTION; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS LOAD; AIDS RELATED COMPLEX; CASE CONTROL STUDY; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; UTERINE CERVIX TUMOR;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 46049112079     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23504     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Centers for Disease Control and Prevention. MMWR Recommendations and Reports-1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm. Accessed June 6, 2006.
3. Bosch FX, Manos MM, Munoz N, et al. Prevalence ol human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
4. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
5. Jamieson DJ, Duerr A, Burk R, et al. HIV Epidemiology Research Study (HERS) Group. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol. 2002;186:21-27.
6. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577-586.
7. Chin KM, Sidhu JS, Janssen RS, Weber JT. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol. 1998;92:83-87.
8. La Ruche G, Ramon R, Mensah-Ado I, et al. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group. Cancer. 1998;82:2401-2408.
9. Hessol NA, Seaberg EC, Preston-Martin S, et al. for the WIHS Collaborative Study Group. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr. 2004;36:978-985.
10. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001;154:544-556.
11. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J AIDS. 2003;32:527-533.
12. Palefsky J. Biology of HPV in HIV infection. Adv Dent Res. 2006;19:99-105.
13. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA. 1996;276:105-110.
14. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
15. Bower M, Mazhar D, Stebbing J. Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? J Clin Oncol. 2006;24:2417-2419.
16. Maiman M, Fruchter RG, Clark M, Arrastia CD, Matthews R, Gates EJ. Cervical cancer as an AIDS-defining illness. Obstet Gynecol. 1997;89:76-80.
17. Mayans MV, Maguire A, Miret M, Casabona J. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain. Sex Transm Dis. 1999;26:500-503.
18. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev. 1996;9:532-562.
19. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol. 2002;55:19-24.
20. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52:342-362.